Experts in solutions for the Biotechnology and Pharmaceutical sectors.

We are experts in providing comprehensive solutions in the management and preservation of thermolabile samples and medication that requires ultra-low temperatures.
Bioservices Safe and customised solutions
Diagnosis and design Design and implementation of ad hoc emergency plans.
Secure storage Reserve storage space at temperature required for immediate transfer in the event of an emergency.
Fleet of vehicles and equipment Equipos de última tecnología Stirling con rango de temperatura de -20°C a -86°C y flota de vehículos adaptados a las temperaturas requeridas.
Qualified Professional Emergency team prepared and qualified for comprehensive 24/7 service, 365 days a year.
Our Facilities

Our private Biorepository consists of 360 m2 specially adapted to the management and storage service.

Preservation room with the latest Stirling Ultracold technology. Equipment with temperature range of -20 °to -86°C

We have two chambers over 120 m3 for storing samples designed to provide maximum protection.

Capacity for storage of 18.9 million thermolabile medications and 4.4 million biological samples.

Awarded with the maximum standards of quality: ISO 9001, ISO 14001, GDP and authorised storage of medications.

Characteristics of the facilities
Storage traceability, transport and temperature system
Specific software, real-time monitoring 24/7
Highly qualified personnel
Video surveillance, access control, security personnel
Anti-theft and anti-fire system
Outside back-up generator set
Biorepositories network

We form, with Biorepos, a private biorepository network at national level with 3 strategically located branches.

Get to know our services
Do you need help to promote your project? Our 45 years of expertise applied to your needs.

We have a long history of working closely with our customers, complying with the most demanding health regulations. Our presence throughout the value chain sets us apart as a unique partner.

Find out more

Stay up to date on the latest
news from Bexen.